Uipath Inc. logo

Uipath Inc. (PATH)

Market Closed
8 Dec, 20:00
NYSE NYSE
$
19. 29
+0.62
+3.32%
After Hours
$
19. 32
+0.03 +0.16%
7.22B Market Cap
- P/E Ratio
0% Div Yield
31,947,567 Volume
0.48 Eps
$ 18.67
Previous Close
Day Range
18.75 19.84
Year Range
9.38 19.84
Want to track PATH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know

UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know

UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 year ago
UiPath: Great Opportunity To Buy This AI Stock At A Cheap Price

UiPath: Great Opportunity To Buy This AI Stock At A Cheap Price

UiPath is a buy due to its strong recurring revenue, high gross margins, and horizontal product relevance across industries, despite recent sales slowdowns. The company has implemented strategic changes, including leadership shifts, workforce restructuring, and new product launches, to address growth and execution challenges. UiPath's valuation is attractive at

Seekingalpha | 1 year ago
UiPath Inc (PATH) Chief Accounting Officer Sells 25,000 Shares

UiPath Inc (PATH) Chief Accounting Officer Sells 25,000 Shares

On October 3, 2024, Hitesh Ramani, the Chief Accounting Officer of UiPath Inc (PATH, Financial), sold 25,000 shares of the company at a price of $12 per share. The transaction was documented in a recent SEC Filing.

Gurufocus | 1 year ago
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know

UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know

UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 year ago
2 Growth Stocks to Buy Before They Soar 212% and 712%, According to Certain Wall Street Analysts

2 Growth Stocks to Buy Before They Soar 212% and 712%, According to Certain Wall Street Analysts

Morgan Stanley analysts think UiPath stock could return 212% by September 2025, and Ark Invest analysts believe Roku shares could surge 712% by December 2025. UiPath is the market leader in robotic process automation software, and co-founder Daniel Dines was recently reappointed CEO to reinvigorate growth.

Fool | 1 year ago
UiPath Stock Falls 50% Year to Date: Should You Buy the Dip?

UiPath Stock Falls 50% Year to Date: Should You Buy the Dip?

A customer-centric approach, coupled with product innovation using GenAI, benefits PATH.

Zacks | 1 year ago
1 Struggling Artificial Intelligence Stock That Wall Street Analysts Think Could Rally by More Than 40%

1 Struggling Artificial Intelligence Stock That Wall Street Analysts Think Could Rally by More Than 40%

UiPath has struggled this year as its growth rate has been slowing down and it's nowhere near posting a profit. The consensus analyst price target for the stock is nearly $18, suggesting a good amount of upside for investors.

Fool | 1 year ago
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It

UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It

UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 year ago
Could This Be the News UiPath Shareholders Have Been Waiting For?

Could This Be the News UiPath Shareholders Have Been Waiting For?

The market for robotic process automation should expand dramatically. UiPath -- a key player in this cutting-edge field -- has felt some hiccups lately.

Fool | 1 year ago
UiPath Inc.: Bullish Support Is Finally Here - Turnaround Likely Prolonged

UiPath Inc.: Bullish Support Is Finally Here - Turnaround Likely Prolonged

PATH has faced near-term challenges, but shows promise due to its growing customer base, healthy balance sheet, and recent share repurchase authorization. Despite the mixed earnings and decelerating ARR growth, the raised FY2025 guidance and new AI product releases in Q3'24 offer potential for renewed growth opportunities. PATH's valuation remains attractive with a FWD PEG non-GAAP ratio of 1.16x, compared to its automation/AI SaaS peers.

Seekingalpha | 1 year ago
Down 52% in 2024, Is UiPath Stock a Bargain Now?

Down 52% in 2024, Is UiPath Stock a Bargain Now?

The robotic process-automation industry that UiPath pioneered is growing rapidly. UiPath has been losing market share to C3.ai and Microsoft.

Fool | 1 year ago
Down 45% On the Year, Is This a Golden Opportunity to Buy UiPath Stock After It Issues Upbeat Guidance?

Down 45% On the Year, Is This a Golden Opportunity to Buy UiPath Stock After It Issues Upbeat Guidance?

UiPath reported solid Q2 results following its disastrous Q1 report. The company is seeing strong renewal rates and net dollar retention.

Fool | 1 year ago
Loading...
Load More